Fidelity had this as a headline with MNKD news. Such a bunch of BS to mention Zyprexa in the same sentance as MNKD. Its a psycotic drug that has absolutley nothing to do with MNKD. Big time scare tactic. Talk about pulling out all the stops for a short attack.

>>>MannKind plunges as FDA investigates two death after Zyprexa injections 06/18 10:30 AM

The shares are down over 21.7% to $5.90 after news the FDA is looking into two deaths that followed injections with Zyprexa. At current price, next support is at $5.70, the low of the day so far, and then at $5.51. Resistance is at $6.23, and then at $6.54.<<<